𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intralesional rituximab for cutaneous B-cell lymphoma

✍ Scribed by T. Paul; P. Radny; S.M. Kröber; A. Paul; H-J. Blaheta; C. Garbe

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
538 KB
Volume
144
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab in cutaneous B-cell lymphoma:
Rituximab in cutaneous B-cell lymphoma: a report of two cases
✍ R.A. Sabroe; F.J. Child; A.J. Woolford; M.F. Spittle; R. Russell-Jones 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

We report two patients with primary cutaneous B-cell lymphoma who were treated with rituximab, a new anti-CD20 monoclonal antibody. The first patient, who had a diffuse large B-cell lymphoma of the lower leg, achieved an 85% improvement. The second patient, who had a primary cutaneous B-cell lymphom